Your Pharmacy Won't Tell You Where the API Comes From — Here's Why That Matters Less Than You Think

You ask your compounder where the semaglutide API comes from. The answer is either a category ('DMF-supported manufacturer in China'), a vague reassurance, or silence. Frustrating? Yes. But the specific manufacturer name matters less than a handful of other things — here's what to focus on instead.

Why Pharmacies Don't Disclose

There are three legitimate reasons a pharmacy might not name its API supplier publicly. First, competitive reasons: knowing a competitor's API source is commercially valuable, and pharmacies protect it. Second, contractual reasons: some API suppliers require confidentiality from pharmacy customers as a condition of supply. Third, operational reasons: pharmacies often source from multiple suppliers and don't want to be pinned to a specific one for a specific batch.

None of these reasons is disqualifying. Silence on the specific supplier is common industry practice, not a sign of hiding a bad source.

What Actually Matters More

What matters more than the specific manufacturer name:

• DMF status: Is the API manufacturer registered with the FDA under a Drug Master File? DMF-supported APIs have submitted their manufacturing details to the FDA and can be independently verified.
• Certificate of Analysis: Does the pharmacy have a batch-specific CoA showing testing results for identity, potency, and impurities?
• Independent testing: Does the pharmacy do its own incoming-material testing beyond what the API supplier provides?
• Sterility processes: What USP <797>/<795> processes does the pharmacy follow?
• Accreditation: Is the pharmacy PCAB or ACHC accredited?

A pharmacy with strong answers to all of the above but no supplier name is on stronger ground than a pharmacy that names its supplier but has weak testing and accreditation.

What to Ask Instead

Reframe the question. Instead of "who's your API supplier," ask: "Is your API DMF-supported and can you confirm the DMF number?" "Do you have a current Certificate of Analysis for the semaglutide batch shipping to me?" "What incoming-material testing do you perform?" "Are you PCAB or ACHC accredited?" "What's your USP <797> compliance status?"

These questions get you information that actually predicts product quality. A pharmacy with clean answers to all five is on strong footing regardless of whether it names the API supplier.

When Silence Is a Real Red Flag

Silence on API supplier is normal. Silence on DMF status, unwillingness to provide a Certificate of Analysis on request, no incoming-material testing, no accreditation, and unclear USP compliance — that combination is a real red flag. A pharmacy that declines every documentation question, not just the supplier one, is a pharmacy operating with less transparency than the modern compounding market expects.

The Reasonable Standard

Most well-run compounding pharmacies will disclose the substance of what they do — DMF status, CoA availability, testing scope, accreditation — even when they won't name the specific supplier. That level of disclosure is the reasonable standard in 2026. If you're getting less than that, ask more directly. If you still get less than that, consider it a signal.

Where to Start